The Food and Drug Administration (FDA) has removed its boxed warning from more than twenty hormone-based therapies used to treat menopause symptoms, marking a major change in how the agency regulates these medications. The FDA’s update applies to products that deliver estrogen or estrogen-progestin combinations through pills, patches, gels, or sprays. The boxed warning, also […]